Pepsin-catalyzed Plastein Reaction with Tryptophan Increases the in Vitro Activity of Lactoferrin Hydrolysates with BGC-823 Cells

Chun-Min Ma,Tie-Jing Li,Xin-Huai Zhao
DOI: https://doi.org/10.1016/j.fbio.2019.01.013
IF: 5.318
2019-01-01
Food Bioscience
Abstract:Lactoferrin hydrolysates (LF-H) were digested using pepsin and modified using a pepsin-catalyzed plastein reaction with tryptophan (Trp) to obtain a target product. LF-H, the target product, plastein reaction-modified LFH alone, and a mixture of LF-H and Trp were evaluated for their activities with human gastric cancer BGC823 cells at 24 and 48 h. Assay results indicated that the target product had decreased free amino groups and had incorporated Trp. LF-H and the plastein reaction-modified LF-H alone did not show detectable growth inhibition on BGC-823 cells at 1-3 mg/mL; however, the target product at the same dose levels inhibited cell growth, and showed higher activity than the mixture (P < 0.05). The target product at 2 and 3 mg/mL stopped cell cycle progression at the G0/G1-phase, induced DNA fragmentation, and showed apoptosis induction, which increased the number of apoptotic cells. Moreover, time-and dose-dependent responses were observed in these experiments. RT-PCR assay results indicated that exposure of the cells to the target product resulted in up-and downregulated mRNA expression for 7 apoptosis-related genes, namely Bcl-2, Bcl-xl, Bad, Bax, caspase-3, caspase-6, and caspase-9. Thus, the plastein reaction increased in vitro anticancer activities of LF-H with BGC-823 cells, and more importantly, both the plastein reaction and Trp incorporation contributed to enhanced activities.
What problem does this paper attempt to address?